Innovative Health, Inc. stated it has received a U.S. patent for a microlumen reprocessing technology to help ensure patient safety while advancing the discipline of reprocessing single-use cardiology medical devices.
The patent covers a novel test method for identifying subvisible occluding particles in microlumens. The testing method covered by the new patent was the result of many months of dialogue between Innovative Health and the U.S. Food and Drug Administration that resulted in a new standard for ensuring the safe reprocessing of electrophysiology (EP) devices containing microlumens.
The patented testing method is currently being leveraged by Innovative Health for the reprocessing of the Reprocessed PentaRay Nav Eco High-Density Mapping Catheter (Bio-sense Webster), the Reprocessed Advisor HD Grid Mapping Catheter (St. Jude Medical), the Reprocessed BRK Transseptal Needle (St. Jude Medical) and the Reprocessed NRG Transseptal Needle (Baylis Medical).
Innovative Health is building a patent portfolio to expand the ability of EP labs to reduce costs without sacrificing quality and safety. The company’s expanding intellectual property portfolio will clear the path to push reprocessing of devices outside of the EP lab to adjacent technologies within cardiology.
